Effects of liraglutide on beta-cell function in type 2 diabetic patients with secondary failure to oral hypoglycemic agents. A randomized, controlled, parallel groups, open-label, phase II study [Effetti di liraglutide sulla funzione cellulare nei pazienti con diabete tipo 2 in fallimento secondario agli ipoglicemizzanti orali. Studio di fase II, randomizzato, controllato, a gruppi paralleli, in aperto]

Trial Profile

Effects of liraglutide on beta-cell function in type 2 diabetic patients with secondary failure to oral hypoglycemic agents. A randomized, controlled, parallel groups, open-label, phase II study [Effetti di liraglutide sulla funzione cellulare nei pazienti con diabete tipo 2 in fallimento secondario agli ipoglicemizzanti orali. Studio di fase II, randomizzato, controllato, a gruppi paralleli, in aperto]

Recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Jan 2014

At a glance

  • Drugs Liraglutide (Primary) ; Glimepiride
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top